The maple leaves are red and the osmanthus is fragrant. In this wonderful season, Cole has ushered in a new era of development. Cole's carefully crafted pet series products are grandly launched, e-commerce platforms such as Tmall, Douyin, and Kuaishou have made their debut, and Cole's official flagship store is dressed up to welcome customers. This is the first time that the Cole pet product brand has entered a third-party e-commerce platform globally, and has joined forces with various e-commerce platforms to open a new model of e-commerce cooperation. The Cole pet product brand will combine offline physical stores and online e-commerce platforms to bring global consumers a comprehensive shopping experience and more considerate VIP services.

Keer Pharmaceutical was established in 1999, located in Located in the National Economic and Technological Development Zone in Tongcheng City, Anhui Province, it has a registered capital of 50 million yuan and currently has more than 180 employees, including more than 20 with high and intermediate professional titles. Keer Pharmaceutical is an enterprise that has passed the Ministry of Agriculture’s new version of veterinary drug GMP acceptance, and an enterprise that has passed the Ministry of Agriculture’s feed additive acceptance. The company has 13 production lines for veterinary water injections, powders, Chinese medicine powders, Chinese medicine extractions, oral liquids, uterine infusions, breast infusions, tablets, granules, liquid disinfectants, solid disinfectants and feed additives. The company has long been committed to the research and development of advanced antibiotics and ultra-micron veterinary drugs, and has achieved fruitful results.

The national new veterinary drug "Enrofloxacin Veterinary Uterine Injection" jointly developed by Cole Pharmaceuticals, South China Agricultural University and Qingdao Agricultural University is the first of its kind in China and has obtained a national patent. The production and application of veterinary enteric-coated powder, an integrated industry-university-research cooperation project between Kerr Pharmaceutical and South China Agricultural University, has achieved significant economic and social benefits. The ultra-micron Chinese veterinary drug "Lanyuanling" launched by Cole Pharmaceuticals has proven effectiveness in preventing and controlling pig blue-ear disease and is being promoted and applied on a large scale. In the past few years, Cole has obtained more than ten national patents for inventions or utility models, which has effectively promoted the continuous progress of preparation technology. This year, Cole Pharmaceuticals has been awarded the title of National High-tech Enterprise, which is the greatest incentive and spur for Cole's scientific and technological innovation over the years.

In order to adapt to the development of the market, Keer Pharmaceutical Pet The product project has been grandly launched. Cole people regard "pet health care provider" as the development vision of the enterprise and are determined to do so. Kerren uses a number of invention patents such as modern herbal extraction technology, immune protein peptide technology, and micromolecular iron technology as technical support. With its rich experience in the research and development and product manufacturing of pet drugs, health products, functional and prescription foods, We strive to develop better and higher-quality products in the pet field. Cole people make full use of online platforms, flagship stores and other online channels to break the limitations of time and space and enjoy a convenient and comfortable shopping process with 24-hour seamless connection. They are 100% authentic and create a new global high-quality online shopping experience.